Richard Daniell Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

Richard Daniell is Exec. VP, European Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 48,384 shares of TEVA, which is worth approximately $743,662. The most recent transaction as insider was on Mar 04, 2022, when has been sold 59,278 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.4K

Infinity% 3M change

51.1% 12M change

Total Value Held $743,662

Richard Daniell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2022	BUY Exercise of conversion of derivative security	-	59,278 Added 48.23%	63,638 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$167,668 $8.14 p/Share	20,598 Reduced 50.39%	20,280 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	20,598 Added 33.51%	40,878 Ordinary Shares
Feb 09 2022	SELL Open market or private sale	$119,003 $9.06 p/Share	13,135 Reduced 39.31%	20,280 Ordinary Shares
Feb 09 2022	BUY Exercise of conversion of derivative security	-	13,135 Added 28.22%	33,415 Ordinary Shares
Mar 04 2021	SELL Open market or private sale	$79,488 $10.58 p/Share	7,513 Reduced 27.03%	20,280 Ordinary Shares
Mar 04 2021	BUY Exercise of conversion of derivative security	-	15,920 Added 36.42%	27,793 Ordinary Shares
Mar 03 2021	SELL Open market or private sale	$10,804 $10.88 p/Share	993 Reduced 7.72%	11,873 Ordinary Shares
Mar 03 2021	BUY Exercise of conversion of derivative security	-	2,101 Added 14.04%	12,866 Ordinary Shares
Mar 01 2021	SELL Open market or private sale	$223,488 $10.85 p/Share	20,598 Reduced 65.68%	10,765 Ordinary Shares
Feb 28 2021	BUY Exercise of conversion of derivative security	-	20,598 Added 39.64%	31,363 Ordinary Shares
Feb 09 2021	SELL Open market or private sale	$870,328 $12.72 p/Share	68,422 Reduced 86.41%	10,765 Ordinary Shares
Feb 09 2021	BUY Grant, award, or other acquisition	-	55,287 Added 41.11%	79,187 Ordinary Shares
Feb 09 2021	BUY Exercise of conversion of derivative security	-	13,135 Added 35.47%	23,900 Ordinary Shares

Richard Daniell

Exec. VP, European Commercial

Tel Aviv, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Value

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA

Account